How to manage a Tesla trade, with CNBC's Sara Eisen and the Options Action traders.» Read More
Gold is up 5 percent on the year. Is there a bullion breakout ahead? With CNBC's Bertha Coombs and the Futures Now Traders.
Will S&P 2000 bring the retail money into the market? Howard Silverblatt doesn¿t think so. With CNBC's Bertha Coombs and the Futures Now Traders.
The euro keeps falling. How low can it go? Trading the euro now, with CNBC's Bertha Coombs and the Futures Now Traders.
Howard Silverblatt of S&P Dow Jones Indices explains why the fundamentals of the market still look promising. With CNBC's Bertha Coombs and the Futures Now Traders.
The S&P hits a record high. What it means and the market's next move, with Howard Silverblatt, S&P Dow Jones Indices, CNBC's Bertha Coombs and the Futures Now Traders, Jeff Kilburg and Scott Nations, both at the CME.
CNBC's Jim Cramer explains why he is watching Mobileye and Wendy's.
Jim Cramer explains what to watch ahead of the open, including DSW and GT Advanced Technologies. Cramer also reveals some undervalued stocks that took the S&P to 2,000.
If you’re looking to put money to work in pharma, Cramer thinks Mallinckrodt, a maker of drugs to control pain, may warrant attention.
If you’re lamenting the recent decline in this stock, both Jim Cramer and the company’s CEO would like a word.
With declines of 30 percent year to date, you may be thinking about nibbling on these stocks. Cramer, however, says they're far from delectable.
Mark Trudeau, Mallinckrodt Pharmaceuticals president and CEO, discusses the company's focus on strategy and acquisitions, with Mad Money host Jim Cramer.
Mad Money's Jim Cramer takes a closer look at restaurant stocks that have been losing their appetite for money.
With the S&P piercing 2000 intraday Monday, Cramer fully expects to hear nay-sayers single out the Fed. Can the rally endure?
Mad Money host Jim Cramer focuses on profits and corporate profits growing at accelerating speeds moving the market higher.
The Fast Money traders share their final trades of the day.
Proteus Digital Health has created an ingestible sensor that will track drug activity and send the data to mobile devices. Andrew Thompson, CEO and co-founder, explains.
The Fast Money traders take a look at today's biggest market movers.
With the S&P 500 hitting the 2,000 level, the FM traders reveal stocks to sell.
Peter Keith, Piper Jaffray, discusses how the release of Apple's iPhone 6 may affect Best Buy's bottom line.
Dennis Gartman of The Gartman Letter outlines how far he expects oil prices to go.